Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Dec 18;12(1):13. doi: 10.3390/cancers12010013

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Identification of the PSAT1 gene as a biomarker candidate of lower-grade gliomas. The expression status of PSAT1 in tumors and normal tissues were obtained from the bioinformatics website, GEPIA. (A) The expression levels of PSAT1 in various tumors. Gene levels of PSAT1 were highly expressed in LGGs and GBMs. (B) The expression levels of PSAT1 in LGGs, GBMs and normal tissues. The expression levels of PSAT1 were significantly higher in tumors (LGGs and GBMs) than in normal tissues. (C) The prognostic significance of PSAT1 expression in the TCGA LGG cohort. Patients were divided into two subgroups according to PSAT1 expression for survival analysis.

Identification of the PSAT1 gene as a biomarker candidate of lower-grade gliomas. The expression status of PSAT1 in tumors and normal tissues were obtained from the bioinformatics website, GEPIA. (A) The expression levels of PSAT1 in various tumors. Gene levels of PSAT1 were highly expressed in LGGs and GBMs. (B) The expression levels of PSAT1 in LGGs, GBMs and normal tissues. The expression levels of PSAT1 were significantly higher in tumors (LGGs and GBMs) than in normal tissues. (C) The prognostic significance of PSAT1 expression in the TCGA LGG cohort. Patients were divided into two subgroups according to PSAT1 expression for survival analysis.